🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Retosiban

Found 9 matching trials

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

PHASE3

The primary objective of this study is to assess the safety and outcomes of...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-06-01

Trial ID

NCT02292784

Treatments Being Tested

Retosiban Atosiban Placebo

Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women

PHASE1

This study in healthy, adult Japanese women will characterize the PK, safet...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-03-02

Trial ID

NCT02377414

Treatments Being Tested

Retosiban solution for Infusion Placebo

A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour

PHASE3

The primary objective of this study is to demonstrate the superiority of re...

Status

Terminated

Location

GSK Investigational Site

Start Date

2015-03-16

Trial ID

NCT02292771

Treatments Being Tested

Retosiban Atosiban Placebo matching retosiban Placebo matching atosiban

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)

PHASE1

This will be a randomized single sequence open label study. This study is d...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-06-11

Trial ID

NCT01867996

Treatments Being Tested

Retosiban EFZ 600 mg

A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor

PHASE3

The study's primary objective is to demonstrate the superiority of retosiba...

Status

Terminated

Location

GSK Investigational Site

Start Date

2016-02-29

Trial ID

NCT02377466

Treatments Being Tested

Retosiban IV infusion Placebo IV infusion

A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole

PHASE1

This is a two part study. Part A of the study will evaluate the metabolites...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-12-12

Trial ID

NCT01627587

Treatments Being Tested

GSK221149 750 mg Ketoconazole GSK221149 100 mg GSK221149 750 mg Fasted GSK221149 750 mg + Food

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

PHASE2

Pre-Term Labor (prior to 37 weeks gestation) is the largest single cause of...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-10-12

Trial ID

NCT00404768

Treatments Being Tested

GSK221149A Placebo

This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.

PHASE1

This will be a randomized, placebo-controlled, single, oral dose, four-way ...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-10-03

Trial ID

NCT01702376

Treatments Being Tested

Retosiban 100 mg Retosiban 800 mg Placebo Moxifloxacin 400 mg

Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

PHASE1

This is a phase one study investigating the absorption, distribution, metab...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-10

Trial ID

NCT00457925

Treatments Being Tested

GSK221149A

Previous Next